Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study)

Condition:   Head and Neck Neoplasms
Interventions:   Drug: Afatinib Oral Tablet;   Drug: Pembrolizumab Injection
Sponsor:   National Taiwan University Hospital
Not yet recruiting

https://ift.tt/2xV1jIk